Hiran Orgochem to invest up to $5 million in WOS to be set up in Mauritius

01 Jun 2013 Evaluate

Hiran Orgochem has received an approval to invest the GDR proceeds of up to $5 million in wholly-owned subsidiary (WOS) to be set up in Mauritius. The board of directors at its meeting held on May 31, 2013 has approved for the same.

Hiran Orgochem is a leading integrated manufacturer of active pharmaceutical ingredients and formulations. Since its incorporation, the company has focused on Manufacturing the Quinolones group of API's with its principal products comprising Ciprofloxacin, Ofloxacin, Levofloxacin, Enrofloxacin and now provides formulations as well.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×